Stock Research for ATTBF

ATTBF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ATTBF Stock Chart & Research Data

The ATTBF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATTBF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ATTBF Due diligence Resources & Stock Charts

The ATTBF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATTBF Detailed Price Forecast - CNN Money CNN View ATTBF Detailed Summary - Google Finance
Yahoo View ATTBF Detailed Summary - Yahoo! Finance Zacks View ATTBF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ATTBF Trends & Analysis - Trade-Ideas Barrons View ATTBF Major Holders - Barrons
NASDAQ View ATTBF Call Transcripts - NASDAQ Seeking View ATTBF Breaking News & Analysis - Seeking Alpha
Spotlight View ATTBF Annual Report - CompanySpotlight.com OTC Report View ATTBF OTC Short Report - OTCShortReport.com
TradeKing View ATTBF Fundamentals - TradeKing Charts View ATTBF SEC Filings - Bar Chart
WSJ View Historical Prices for ATTBF - The WSJ Morningstar View Performance/Total Return for ATTBF - Morningstar
MarketWatch View the Analyst Estimates for ATTBF - MarketWatch CNBC View the Earnings History for ATTBF - CNBC
StockMarketWatch View the ATTBF Earnings - StockMarketWatch MacroAxis View ATTBF Buy or Sell Recommendations - MacroAxis
Bullish View the ATTBF Bullish Patterns - American Bulls Short Pains View ATTBF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ATTBF Stock Mentions - StockTwits PennyStocks View ATTBF Stock Mentions - PennyStockTweets
Twitter View ATTBF Stock Mentions - Twitter Invest Hub View ATTBF Investment Forum News - Investor Hub
Yahoo View ATTBF Stock Mentions - Yahoo! Message Board Seeking Alpha View ATTBF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ATTBF - SECform4.com Insider Cow View Insider Transactions for ATTBF - Insider Cow
CNBC View ATTBF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATTBF - OTC Markets
Yahoo View Insider Transactions for ATTBF - Yahoo! Finance NASDAQ View Institutional Holdings for ATTBF - NASDAQ


Stock Charts

FinViz View ATTBF Stock Insight & Charts - FinViz.com StockCharts View ATTBF Investment Charts - StockCharts.com
BarChart View ATTBF Stock Overview & Charts - BarChart Trading View View ATTBF User Generated Charts - Trading View




Latest Financial News for ATTBF


Abattis Strengthens Management Team and Provides Company Updates
Posted on Tuesday September 11, 2018

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide the following corporate updates. The Company is pleased to announce the appointment of Nicole Breitinger as the Company’s corporate secretary. Ms. Breitinger brings considerable experience to her role, having spent more than twenty years providing corporate services to companies across a range of industries.


Abattis Prepares to Launch New Products Through Vergence Naturals
Posted on Tuesday August 28, 2018

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce that it plans to launch a new line of products designed to alleviate pain and inflammation through its wholly owned subsidiary, Vergence Naturals Ltd. (“Vergence”). The launch is anticipated to take place on Cyber Monday and the new product line will be the first of twelve products the Company hopes to launch over a 36-month period. “We are very proud to have developed two products that safely reduce pain and modulate inflammation.


Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada
Posted on Wednesday August 15, 2018

Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act. The dealer license allows Emerald to participate in the growing market for cannabis analytical testing, which Emerald expects to grow in conjunction with increasing cannabis production volumes in Canada.


Abattis Completes Sale of Northern Vine Interest
Posted on Tuesday August 14, 2018

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce that it has completed the sale (the “Sale”) of its 35% interest in Northern Vine Canada Inc. (“Northern Vine”) to Emerald Health Therapeutics, Inc. (TSXV:EMH / OTCQX:EMHTF) (“Emerald”) in exchange for $2 million in cash and $4 million in common shares of Emerald, 50% of which are free trading and 50% of which may be sold in 30 days. The share purchase agreement governing the Disposition (the “Agreement”) also provides that, upon Northern Vine and/or Emerald earning gross revenues of $10 million from the sale of products or provision of services to customers introduced by Abattis, Emerald will issue Abattis an additional $4 million in common shares of Emerald.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.